Rare cell isolation using antibodies covalently linked to slides: application to fetal cells in maternal blood

Prenat Diagn. 2003 Nov;23(11):898-900. doi: 10.1002/pd.712.

Abstract

We describe here a new type of method for isolation of rare cell populations in biological fluids. The method is based on the anthraquinone technology for covalent binding of molecules to a polymer surface. An anthraquinone molecule conjugated via a linker to an electrophilic group (AQ Immobilizer trade mark reagent, Exiqon A/S) is covalently bound to a polymer surface by UV irradiation. The electrophilic group of this AQ reagent can covalently bind a specific antibody directed against a specific cell marker. Applying a cell sample to the functional surface, the cells having the specific cell marker on the cell surface will bind to the antibody on the functional surface. Using this technique, even extremely small cell populations may be isolated. We succeeded in isolating fetal cells from maternal blood samples in the first trimester for chromosome defects genetic diagnosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anthraquinones / chemistry
  • Anthraquinones / immunology
  • Antibodies, Monoclonal / immunology*
  • Cell Separation / methods*
  • Erythroblasts / cytology
  • Erythroblasts / immunology
  • Female
  • Fetal Blood / cytology
  • Fetal Blood / immunology*
  • Fetomaternal Transfusion / immunology*
  • Gestational Age
  • Humans
  • In Situ Hybridization, Fluorescence
  • Infant, Newborn
  • Male
  • Photochemistry
  • Polymers / chemistry
  • Pregnancy / blood*
  • Prenatal Diagnosis / methods*
  • Reproducibility of Results
  • Surface Properties

Substances

  • Anthraquinones
  • Antibodies, Monoclonal
  • Polymers